414 related articles for article (PubMed ID: 35130610)
1. Foe and friend in the COVID-19-associated acute kidney injury: an insight on intrarenal renin-angiotensin system.
Xu C; Chen Y; Yu J
Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(1):1-11. PubMed ID: 35130610
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019.
Suh SH; Ma SK; Kim SW; Bae EH
Korean J Intern Med; 2021 Mar; 36(2):247-262. PubMed ID: 33617712
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
Shukla AK; Banerjee M
High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
[TBL] [Abstract][Full Text] [Related]
4. Fiend and friend in the renin angiotensin system: An insight on acute kidney injury.
Sharma N; Anders HJ; Gaikwad AB
Biomed Pharmacother; 2019 Feb; 110():764-774. PubMed ID: 30554115
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptors: Impact for COVID-19 severity.
Aksoy H; Karadag AS; Wollina U
Dermatol Ther; 2020 Nov; 33(6):e13989. PubMed ID: 32645228
[TBL] [Abstract][Full Text] [Related]
6. A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19.
Malek Mahdavi A
Rev Med Virol; 2020 Sep; 30(5):e2119. PubMed ID: 32584474
[TBL] [Abstract][Full Text] [Related]
7. Two hits to the renin-angiotensin system may play a key role in severe COVID-19.
Tseng YH; Yang RC; Lu TS
Kaohsiung J Med Sci; 2020 Jun; 36(6):389-392. PubMed ID: 32492292
[TBL] [Abstract][Full Text] [Related]
8. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury.
Sarzani R; Giulietti F; Di Pentima C; Giordano P; Spannella F
Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L325-L336. PubMed ID: 32639866
[TBL] [Abstract][Full Text] [Related]
9. Androgens, the kidney, and COVID-19: an opportunity for translational research.
Yanes Cardozo LL; Rezq S; Pruett JE; Romero DG
Am J Physiol Renal Physiol; 2021 Feb; 320(2):F243-F248. PubMed ID: 33464168
[TBL] [Abstract][Full Text] [Related]
10. ACE2 in the renin-angiotensin system.
Verano-Braga T; Martins ALV; Motta-Santos D; Campagnole-Santos MJ; Santos RAS
Clin Sci (Lond); 2020 Dec; 134(23):3063-3078. PubMed ID: 33264412
[TBL] [Abstract][Full Text] [Related]
11. ACE2: from protection of liver disease to propagation of COVID-19.
Warner FJ; Rajapaksha H; Shackel N; Herath CB
Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin system blockade on angiotensin-converting enzyme 2 and TMPRSS2 in human type II pneumocytes.
Silva MG; Falcoff NL; Corradi GR; Alfie J; Seguel RF; Tabaj GC; Iglesias LI; Nuñez M; Guman GR; Gironacci MM
Life Sci; 2022 Mar; 293():120324. PubMed ID: 35032553
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].
Sun ML; Yang JM; Sun YP; Su GH
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):219-222. PubMed ID: 32164092
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries.
Wang K; Gheblawi M; Nikhanj A; Munan M; MacIntyre E; O'Neil C; Poglitsch M; Colombo D; Del Nonno F; Kassiri Z; Sligl W; Oudit GY
Hypertension; 2022 Feb; 79(2):365-378. PubMed ID: 34844421
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin converting enzyme 2 at the interface between renin-angiotensin system inhibition and coronavirus disease 2019.
Siri-Angkul N; Chattipakorn SC; Chattipakorn N
J Physiol; 2020 Oct; 598(19):4181-4195. PubMed ID: 32710575
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases.
El-Arif G; Khazaal S; Farhat A; Harb J; Annweiler C; Wu Y; Cao Z; Kovacic H; Abi Khattar Z; Fajloun Z; Sabatier JM
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408447
[TBL] [Abstract][Full Text] [Related]
17. Therapy with RAS inhibitors during the COVID-19 pandemic.
Spaccarotella C; Mazzitelli M; Migliarino S; Curcio A; De Rosa S; Torti C; Indolfi C
J Cardiovasc Med (Hagerstown); 2021 May; 22(5):329-334. PubMed ID: 33795584
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor.
Oz M; Lorke DE; Kabbani N
Pharmacol Ther; 2021 May; 221():107750. PubMed ID: 33275999
[TBL] [Abstract][Full Text] [Related]
19. Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment.
Chappell MC
Circ Res; 2023 May; 132(10):1320-1337. PubMed ID: 37167353
[TBL] [Abstract][Full Text] [Related]
20. Potential Roles of the Renin-Angiotensin System in the Pathogenesis and Treatment of COVID-19.
Lu L; Liu X; Jin R; Guan R; Lin R; Qu Z
Biomed Res Int; 2020; 2020():7520746. PubMed ID: 33204713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]